These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 26621761)

  • 1. Novartis Compiles Mouse Avatar "Encyclopedia".
    Poh A
    Cancer Discov; 2016 Jan; 6(1):5-6. PubMed ID: 26621761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated analysis of transcriptome in cancer patient-derived xenografts.
    Li H; Zhu Y; Tang X; Li J; Li Y; Zhong Z; Ding G; Li Y
    PLoS One; 2015; 10(5):e0124780. PubMed ID: 25951608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. US cancer institute to overhaul tumour cell lines.
    Ledford H
    Nature; 2016 Feb; 530(7591):391. PubMed ID: 26911756
    [No Abstract]   [Full Text] [Related]  

  • 4. Molecular and clinical implementations of ovarian cancer mouse avatar models.
    Zayed AA; Mandrekar SJ; Haluska P
    Chin Clin Oncol; 2015 Sep; 4(3):30. PubMed ID: 26408297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer Cell Line Encyclopedia launched by Novartis and Broad Institute.
    Marum L
    Future Med Chem; 2012 May; 4(8):947. PubMed ID: 22826900
    [No Abstract]   [Full Text] [Related]  

  • 6. The future of patient-derived tumor xenografts in cancer treatment.
    Sia D; Moeini A; Labgaa I; Villanueva A
    Pharmacogenomics; 2015; 16(14):1671-83. PubMed ID: 26402657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient-derived xenografts for childhood solid tumors: a valuable tool to test new drugs and personalize treatments.
    Zarzosa P; Navarro N; Giralt I; Molist C; Almazán-Moga A; Vidal I; Soriano A; Segura MF; Hladun R; Villanueva A; Gallego S; Roma J
    Clin Transl Oncol; 2017 Jan; 19(1):44-50. PubMed ID: 27718156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What's Next for Patient-Derived Xenograft Modeling?
    Gritters J
    J Natl Cancer Inst; 2017 Jul; 109(7):. PubMed ID: 29982758
    [No Abstract]   [Full Text] [Related]  

  • 9. Prioritizing therapeutic targets using patient-derived xenograft models.
    Lodhia KA; Hadley AM; Haluska P; Scott CL
    Biochim Biophys Acta; 2015 Apr; 1855(2):223-34. PubMed ID: 25783201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Building avatar armies with fish and flies.
    Neff EP
    Lab Anim (NY); 2020 Apr; 49(4):101-104. PubMed ID: 32210417
    [No Abstract]   [Full Text] [Related]  

  • 11. High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response.
    Gao H; Korn JM; Ferretti S; Monahan JE; Wang Y; Singh M; Zhang C; Schnell C; Yang G; Zhang Y; Balbin OA; Barbe S; Cai H; Casey F; Chatterjee S; Chiang DY; Chuai S; Cogan SM; Collins SD; Dammassa E; Ebel N; Embry M; Green J; Kauffmann A; Kowal C; Leary RJ; Lehar J; Liang Y; Loo A; Lorenzana E; Robert McDonald E; McLaughlin ME; Merkin J; Meyer R; Naylor TL; Patawaran M; Reddy A; Röelli C; Ruddy DA; Salangsang F; Santacroce F; Singh AP; Tang Y; Tinetto W; Tobler S; Velazquez R; Venkatesan K; Von Arx F; Wang HQ; Wang Z; Wiesmann M; Wyss D; Xu F; Bitter H; Atadja P; Lees E; Hofmann F; Li E; Keen N; Cozens R; Jensen MR; Pryer NK; Williams JA; Sellers WR
    Nat Med; 2015 Nov; 21(11):1318-25. PubMed ID: 26479923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A personalized preclinical model to evaluate the metastatic potential of patient-derived colon cancer initiating cells.
    Puig I; Chicote I; Tenbaum SP; Arqués O; Herance JR; Gispert JD; Jimenez J; Landolfi S; Caci K; Allende H; Mendizabal L; Moreno D; Charco R; Espín E; Prat A; Elez ME; Argilés G; Vivancos A; Tabernero J; Rojas S; Palmer HG
    Clin Cancer Res; 2013 Dec; 19(24):6787-801. PubMed ID: 24170545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What role could organoids play in the personalization of cancer treatment?
    Francies HE; Garnett MJ
    Pharmacogenomics; 2015; 16(14):1523-6. PubMed ID: 26485224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Generation and Application of Patient-Derived Xenograft Model for Cancer Research.
    Jung J; Seol HS; Chang S
    Cancer Res Treat; 2018 Jan; 50(1):1-10. PubMed ID: 28903551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comprehensively characterized large panel of head and neck cancer patient-derived xenografts identifies the mTOR inhibitor everolimus as potential new treatment option.
    Klinghammer K; Raguse JD; Plath T; Albers AE; Joehrens K; Zakarneh A; Brzezicha B; Wulf-Goldenberg A; Keilholz U; Hoffmann J; Fichtner I
    Int J Cancer; 2015 Jun; 136(12):2940-8. PubMed ID: 25404014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticancer drug sensitivity prediction in cell lines from baseline gene expression through recursive feature selection.
    Dong Z; Zhang N; Li C; Wang H; Fang Y; Wang J; Zheng X
    BMC Cancer; 2015 Jun; 15():489. PubMed ID: 26121976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole-Exome Sequencing of Metastatic Cancer and Biomarkers of Treatment Response.
    Beltran H; Eng K; Mosquera JM; Sigaras A; Romanel A; Rennert H; Kossai M; Pauli C; Faltas B; Fontugne J; Park K; Banfelder J; Prandi D; Madhukar N; Zhang T; Padilla J; Greco N; McNary TJ; Herrscher E; Wilkes D; MacDonald TY; Xue H; Vacic V; Emde AK; Oschwald D; Tan AY; Chen Z; Collins C; Gleave ME; Wang Y; Chakravarty D; Schiffman M; Kim R; Campagne F; Robinson BD; Nanus DM; Tagawa ST; Xiang JZ; Smogorzewska A; Demichelis F; Rickman DS; Sboner A; Elemento O; Rubin MA
    JAMA Oncol; 2015 Jul; 1(4):466-74. PubMed ID: 26181256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moving ahead with personalized mouse models.
    Bender E
    Cancer Discov; 2013 Nov; 3(11):1214. PubMed ID: 24203942
    [No Abstract]   [Full Text] [Related]  

  • 19. Antimetastatic effect of salvicine on human breast cancer MDA-MB-435 orthotopic xenograft is closely related to Rho-dependent pathway.
    Lang JY; Chen H; Zhou J; Zhang YX; Zhang XW; Li MH; Lin LP; Zhang JS; Waalkes MP; Ding J
    Clin Cancer Res; 2005 May; 11(9):3455-64. PubMed ID: 15867248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic treatment with tetra-O-methyl nordihydroguaiaretic acid suppresses the growth of human xenograft tumors.
    Park R; Chang CC; Liang YC; Chung Y; Henry RA; Lin E; Mold DE; Huang RC
    Clin Cancer Res; 2005 Jun; 11(12):4601-9. PubMed ID: 15958646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.